Zymeworks (ZYME) Tax Provisions (2021 - 2026)
Zymeworks (ZYME) reported Tax Provisions of -$2.2 million for Q1 2026, down 541.73% on a YoY basis from $496000.0 in Q1 2025, and down 711.48% sequentially from -$270000.0 in Q4 2025.
Zymeworks (ZYME) Tax Provisions (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Tax Provisions data on file, last reported at -$2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 541.73% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 120.15% YoY), and the FY2025 full-year result was $1.4 million, down 77.38% from the prior year.
- Tax Provisions eased to -$2.2 million in Q1 2026, from -$270000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.0 million in Q4 2022 to a low of -$4.7 million in Q4 2023.
- A 5-year average of $917294.1 and a median of $75000.0 in 2024 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 18477.78% in 2023 and plunged 541.73% in 2026, its largest moves.
- Tracing ZYME's Tax Provisions over 5 years: stood at $11.0 million in 2022, then slumped by 142.91% to -$4.7 million in 2023, then surged by 221.03% to $5.7 million in 2024, then plunged by 104.72% to -$270000.0 in 2025, then plunged by 711.48% to -$2.2 million in 2026.
- Business Quant data shows ZYME's Tax Provisions at -$2.2 million in Q1 2026, -$270000.0 in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.19 Mn |
| Dec 31, 2025 | -270,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -186,000.00 |
| Mar 31, 2025 | 496,000.00 |
| Dec 31, 2024 | 5.72 Mn |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | -4.72 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | -29,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | -74,000.00 |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 764,000.00 |